My a GLP-1 receptor agonist vial sat at 2–8 °C for seven days — is testing worth it before use?

Asked 13 Nov 2025Modified 9 months agoViewed 1.9k times

Details up front: a GLP-1 receptor agonist · 2–8 °C · seven days.

This is a planning question. I know what my options are; I do not know how to weigh them.

What I want is the minimum viable version, which I suspect is smaller than what I would design.

What is the minimum version of this that is still defensible?

Keeping material within a temperature window from manufacture to use: phase-change packs versus dry ice, thermal mass, transit-lane temperature…

524 questionspeptide-stability

peptide-stability

The chemistry of peptide degradation: deamidation, oxidation, hydrolysis, aggregation and fibrillation, and how temperature, pH, ionic strength,…

832 questionsbatch-testing

batch-testing

Testing at the batch or lot level: sampling plans, how many vials from a lot need testing to say anything about the lot, and the difference…

865 questions

shareeditfollowflag

askednoor_alhassan15k2813 Nov 2025

5The distinction between purity and content cannot be repeated often enough here. – ines_brandt 5 months ago

add a comment

No answers yet

This question has not been answered. It has been viewed 1.9k times, which suggests the question is of interest and the answer is not obvious. If you can answer it with a source or a worked calculation, it will be read. See how to ask and answer.

PeptideMeter - Independent Peptide Analytics

Aggregated, published test results and vendor ratings built from submitted batches. Methodology stated, dataset browsable, no listing fees.

Browse results

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.

Linked questions

12 Why did two Homopeptide lots of tirzepatide differ on content assay?6 Why would VendorInvestigate report 96.4% where the supplier certificate says something higher?21 Has anyone independently verified a WWB retatrutide batch COA?17 My tirzepatide vial sat at 2–8 °C for three days — is testing worth it before use?

PeptideMeter

Published, aggregated third-party test data and vendor ratings. Stated methodology.

Browse results

Hot on the stack

What does 96.8% purity on a C4 column actually tell me about a dulaglutide vial?31 votes · 5 answers · 51k views How much of the first four weeks of loss is fluid?30 votes · 5 answers · 49k views What fraction of loss on retatrutide is lean mass according to PIONEER-1?38 votes · 5 answers · 52k views Is ATTAIN-1 a fair comparison of tirzepatide against its comparator arm?38 votes · 5 answers · 52k views My oral semaglutide vial sat at 40 °C for three days — is testing worth it before use?24 votes · 5 answers · 56k views My a GLP-1 receptor agonist vial sat at 40 °C for seven days — is testing worth it before use?35 votes · 2 answers · 54k views What would you ask WuXi TIDES before a first order that they cannot fake?31 votes · 4 answers · 60k views

The stack

Questions5.2k

Answers20k

Accepted3.1k

Unanswered741

Tags107

Users220

Vendors tracked20

My a GLP-1 receptor agonist vial sat at 2–8 °C for seven days — is testing worth it before use?

cold-chain

peptide-stability

batch-testing

No answers yet

PeptideMeter - Independent Peptide Analytics

Your answer

Browse

About